Navigation Links
ULURU Inc. Reports Financial Results for Fourth Quarter and Year Ending December 31, 2011
Date:4/2/2012

valents of approximately $215,000.

Revenues

Revenues for the fourth quarter of 2011 were $256,000, compared to $1,029,000 for the fourth quarter of 2010.  The decrease of approximately $773,000 in revenues from the fourth quarter of 2010 compared to the fourth quarter of 2011 was primarily due to decreased licensing fees as the prior year included the recognition of $751,000 in unamortized licensing fees.

For the year ending December 31, 2011, revenues were $485,000, compared to $1,557,000 for the same period of 2010.  The decrease of approximately $1,072,000 was due primarily to the following factors; a reduction of $988,000 in OraDisc™ related licensing fees and a decrease of $186,000 in Zindaclin® related licensing and royalty fees due to our divestiture of this product in September 2010, this was partially offset by increased product sales.

Research and Development

Research and development expenses for the fourth quarter of 2011 were $198,000, including $17,000 in share-based compensation, compared to $309,000, including $32,000 in share-based compensation, for the fourth quarter of 2010.  The decrease of approximately $111,000 in research and development expenses was primarily was due primarily to lower costs for direct research costs of $85,000.

For the year ending December 2011, research and development expenses were $950,000, including $70,000 in share-based compensation, compared to $1,260,000, including $136,000 in share-based compensation, for the same period in 2010. The decrease of approximately $311,000 in research and development expenses was due primarily to lower costs for regulatory fees of $140,000, direct research costs of $73,000, clinical testing costs for our wound care technologies of $46,000 and scientific compensation costs of $30,000.

Selling, general and administrative

Selling, general and administrative expenses for the fourth quarter o
'/>"/>

SOURCE ULURU Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
2. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
4. ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference
5. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
6. ULURU Inc. Reports Second Quarter 2010 Financial Results
7. ULURU Inc. Announces Conference Call
8. ULURU Inc. Provides Altrazeal® Clinical Update
9. ULURU Inc. Reports Third Quarter 2010 Financial Results
10. ULURU Inc. to Raise $500,000 in Registered Direct Offering
11. ULURU Inc. Announces Agreement With Exciton to Develop Antimicrobial Dressing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015 InfuSystem Holdings, ... infusion pumps and related services for the U.S. healthcare ... and full year 2014 financial results on Monday, March ... Company will also conduct a conference call for investors ... Time to discuss fourth quarter and full year 2014 ...
(Date:3/4/2015)... 4, 2015 Acsis Inc., the market leader ... announced it will be hosting a free webinar on ... "How to Boost Manufacturing Efficiency and Optimize Supply Chain ... 2:00 PM EDT.  Presenters John ... John Gordon , Chief Information Officer for Roosevelt Paper, ...
(Date:3/4/2015)... The March 3, 2015, order from the Federal Drug Administration ... labels to clarify the drugs, intended use and warn about ... to protect the public from injury from these products, according ... Hanly Conroy . The order says that the ... currently taken by millions of U.S. men – are approved ...
Breaking Medicine Technology:Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2
(Date:3/4/2015)... growing influence of movies, television, video games and the internet ... with the increasingly frantic lifestyle of modern parents, it can ... what kids are into these days. It seems that every ... , The same is also true for drugs and alcohol. ... talk about them, are constantly changing. These tips put a ...
(Date:3/4/2015)... Blake’s All Natural Foods , ... attend this year’s Natural Products Expo West in Anaheim, ... this new line, Blake’s, who has the top four ... its commitment to creating high-quality dishes that are easily ... the natural channel, Blake’s understands what educated consumers are ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 More than ... cardiovascular risks potentially associated with low testosterone treatments ( ... announced that it will now require manufacturers to warn ... risk for heart attacks and strokes. In a ... agency also stated that it was requiring testosterone manufacturers ...
(Date:3/4/2015)... 04, 2015 Starting February 2015, Dr. ... PRK procedures at their new location in Surrey. , ... King and Dr. Gabriel Chu also provide comprehensive ophthalmology ... is named Fraser Valley Cataract and Laser (FVCL). This ... the College of Physicians and Surgeons of British Columbia. ...
(Date:3/4/2015)... Vancouver chiropractic clinic, Backs in ... in the prestigious Vancouver Courier “Stars of Vancouver” ... The company secured third place in the “Best ... Registered Massage Therapist” category. , As one ... The Vancouver Courier is a semiweekly local newspaper ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 2Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4Health News:King LASIK relocates to Surrey, British Columbia 2Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2
... patients before flight may prevent many adverse events, researchers ... acutely ill patients who travel by emergency air transport, ... die, suffer from dangerously low blood pressure or need ... Women are at special risk, as are those with ...
... , WALTHAM, Mass., Sept. 15 Decision Resources, ... healthcare issues, finds that the uptake of novel therapies will drive the ... 2008 to more than $3.2 billion in 2018 in the United States, ... The new Pharmacor report entitled Obesity finds that ...
... , , , , ... Systems, Inc., prepares to walk the red carpet on September 15 during ... NOT the same man who blew the whistle on his employer in ... largest price-fixing schemes in corporate history and ultimately landing him in federal ...
... , , JACKSONVILLE, Fla., Sept. ... (BCBSF) announces today its plans to offer coverage for the ... becomes commercially available to the public. The vaccine administration will ... as well as for those members whose plans currently do ...
... , , CRANBURY, N.J., Sept. 15 ... that a poster on clinical trial results with PL-3994, its ... 13th Annual Scientific Meeting of the Heart Failure Society of ... Phase 2A study of PL-3994 in controlled hypertensive volunteers who ...
... , HIGH POINT, N.C., Sept. 15 Dr. ... North Carolina, has formed a company that creates mantra and ... studies have shown that mantras, prayer and meditation techniques can ... problems and ease emotional problems. In many cases, these studies ...
Cached Medicine News:Health News:Emergency Medical Transport By Air Carries Risks 2Health News:The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six-Fold to Over $3.2 Billion in 2018 2Health News:The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six-Fold to Over $3.2 Billion in 2018 3Health News:Former Corporate Whistleblower Says 'The Informant' Movie is Only Part of the Story 2Health News:Former Corporate Whistleblower Says 'The Informant' Movie is Only Part of the Story 3Health News:BCBSF to Cover the Administration of H1N1 Vaccination for All Members 2Health News:Palatin Technologies, Inc. Announces PL-3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 2Health News:Palatin Technologies, Inc. Announces PL-3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 3Health News:Medical Doctor Creates 'Mantra Medicine' Company 2Health News:Medical Doctor Creates 'Mantra Medicine' Company 3
... The DexCom STS Continuous Glucose Monitoring System ... transmits blood glucose readings to the DexCom STS ... sensor which is inserted via the DexCom STS ... the skin where it is held in place ...
... Eclipse,Plus or 850 ECG medical ... capability. Doctors,maintain all the benefits ... and gain the,ability to view ... personal computers., With diagnostic-quality viewing ...
... For practices performing routine ... with QuickStep Wizard provides a,practical, ... tightly managed health care,environment. This ... available in a variety,of configurations ...
... that need an advanced ... Vision,Premier Holter System provides ... Vision Premier system,adds expanded ... comprehensive list of diagnostic,codes ...
Medicine Products: